# Verily Life Sciences

**Type:** Funders  
**Canonical URL:** https://scholariq.org/funders/verily-life-sciences/

## Facts

| Field | Value |
| --- | --- |
| Country | US |
| Description | limited liability company owned by alphabet inc. |
| OpenAlex ID | https://openalex.org/F4320317866 |
| Works | 1,073 |

## Funder papers

- [Canagliflozin and Cardiovascular and Renal Outcomes in Type 2 Diabetes Mellitus and Chronic Kidney Disease in Primary and Secondary Cardiovascular Prevention Groups](https://scholariq.org/papers/canagliflozin-and-cardiovascular-and-renal-outcomes-in-type-2-diabetes-mellitus/)
- [Vericiguat in patients with chronic heart failure and reduced ejection fraction (VICTOR): a double-blind, placebo-controlled, randomised, phase 3 trial](https://scholariq.org/papers/vericiguat-in-patients-with-chronic-heart-failure-and-reduced-ejection-fraction/)
- [Effects of canagliflozin on myocardial infarction: a <i>post hoc</i> analysis of the CANVAS programme and CREDENCE trial](https://scholariq.org/papers/effects-of-canagliflozin-on-myocardial-infarction-a-i-post-hoc-i-analysis-of-the/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.